A real-world study of use of eculizumab in pediatric patients with Atypical haemolytic uraemic syndrome
Latest Information Update: 25 Nov 2020
At a glance
- Drugs Eculizumab (Primary)
- Indications Atypical Haemolytic Uraemic Syndrome
- Focus Adverse reactions; Therapeutic Use
- 25 Nov 2020 New trial record